Vor Biopharma (VOR) Other financing activities (2020 - 2026)

Vor Biopharma (VOR) has 6 years of Other financing activities data on file, last reported at $75.0 million in Q1 2026.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $75.0 million in Q1 2026; TTM through Mar 2026 was $249.4 million, a 1781321.43% increase from a year earlier, with the FY2025 full-year figure at $175.0 million, changed N/A from the prior year.
• Other financing activities for Q1 2026 stood at $75.0 million, down from $174.4 million in the prior quarter.
• Over the last five years, Other financing activities for VOR reached as high as $174.4 million in Q2 2025 and fell as low as $14000.0 in Q1 2023.
• Historically, Other financing activities has averaged $41.7 million across 4 years, with a median of $217000.0 in 2022.
• On a YoY basis, Other financing activities climbed as much as 100.12% in 2022 and fell as far as 99.89% in 2022.
• Year by year, Other financing activities stood at $234000.0 in 2022, then sank by 94.02% to $14000.0 in 2023, then jumped by 1245614.29% to $174.4 million in 2025, then tumbled by 57.0% to $75.0 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $75.0 million in Q1 2026, $174.4 million in Q2 2025, and $14000.0 in Q1 2023.